Clinical Trials

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic

NCT05316116 2026-02-05

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Phase EARLY_PHASE1 Terminated

6 enrolled

Leukemia, Large Granular Lymphocytic

NCT03568994 2026-01-27

ATACC AML

26 enrolled

Leukemia, Myeloid, Acute

NCT07362602 2026-01-23

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

47 enrolled

Hematologic Neoplasms

NCT07362732 2026-01-23

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

20 enrolled

Hematologic Neoplasms

NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

3 enrolled

Hematologic Neoplasms, Renal Insufficiency, Chronic

NCT06662227 2026-01-20

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

30 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT07185490 2026-01-20

IASO104

Other hematologic neoplasmPlasma cell

40 enrolled

Leukemia, Plasma Cell, Multiple Myeloma

NCT06731504 2026-01-16

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Hematologic Neoplasms

NCT07338357 2026-01-13

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Leukemia, Myeloid, Acute

NCT06765876 2026-01-12

UHKT-CAR123-01

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

34 enrolled

Hematologic Neoplasms

NCT06184321 2025-12-26

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

30 enrolled

Hematologic Neoplasms

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Classical hematologyLymphoidOther hematologic neoplasm

28 enrolled

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04744116 2025-11-10

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

24 enrolled

Hematologic Neoplasms

NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

36 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07201727 2025-10-01

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT07144020 2025-08-27

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

50 enrolled

Leukemia, Myeloid, Acute

NCT07126782 2025-08-17

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Leukemia, Myeloid, Acute

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

12 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07123662 2025-08-14

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

8 enrolled

Leukemia

NCT07117175 2025-08-12

A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

Hematologic Neoplasms

NCT03957915 2025-08-06

INA03

33 enrolled

Phase EARLY_PHASE1 Terminated

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

43 enrolled

Neoplasm Metastasis, Hematologic Neoplasms

NCT06988059 2025-08-01

A Study of CT0596 in Plasma Cell Leukemia

Other hematologic neoplasmPlasma cell

27 enrolled

Leukemia, Plasma Cell

NCT05049785 2025-07-25

Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone

100 enrolled

Phase EARLY_PHASE1 Active not recruiting

Leukemia, Lymphoma

NCT05386576 2025-06-15

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

12 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06980155 2025-05-20

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

60 enrolled

Leukemia, Myeloid, Acute

NCT06849401 2025-05-15

The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia

9 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01184885 2025-05-04

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

7 enrolled 8 charts

Burkitt Lymphoma, Recurrence, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01822015 2025-04-29

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

55 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT04628338 2025-04-29

IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

MyeloidOther hematologic neoplasm

8 enrolled

Graft vs Host Disease, Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06904859 2025-04-01

The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia

50 enrolled

Hematologic Diseases, Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT06201247 2025-03-11

Off-the-shelf CD123 CAR-NK for R/R AML

12 enrolled

Phase EARLY_PHASE1 Terminated

Leukemia, Myeloid, Acute

NCT06110208 2025-02-26

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

3 enrolled

Leukemia, Myeloid, Acute

NCT06837389 2025-02-20

Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors

Recurrence, Hematologic Neoplasms

NCT06786299 2025-01-22

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

Leukemia, Myeloid, Acute

NCT06762132 2025-01-07

A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia

27 enrolled

Leukemia, Myeloid, Acute

NCT06756321 2025-01-03

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

9 enrolled

Leukemia, Lymphoma

NCT06718270 2024-12-12

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Other hematologic neoplasmPlasma cell

24 enrolled

Leukemia, Plasma Cell, Multiple Myeloma, Recurrence

NCT05923541 2024-11-22

RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies

6 enrolled

Hematologic Neoplasms

NCT06702098 2024-11-22

iNK-r/r AML

Leukemia, Myeloid, Acute

NCT05716113 2024-11-21

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

20 enrolled

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT05902845 2024-11-21

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

4 enrolled